These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


226 related items for PubMed ID: 17536378

  • 1. Workplace drug testing's mixed success.
    Judge WJ.
    Behav Healthc; 2007 Apr; 27(4):14, 16. PubMed ID: 17536378
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Why drugs and safety don't mix.
    Cholakis P.
    Occup Health Saf; 2006 Aug; 75(8):28, 31-2. PubMed ID: 16944799
    [No Abstract] [Full Text] [Related]

  • 4. Health promotion in the workplace: alcohol and drug abuse. Report of a WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1993 Aug; 833():1-34. PubMed ID: 8367980
    [No Abstract] [Full Text] [Related]

  • 5. Implementation challenges in worksite health promotion programs.
    Birken BE, Linnan LA.
    N C Med J; 2006 Aug; 67(6):438-41. PubMed ID: 17393707
    [No Abstract] [Full Text] [Related]

  • 6. Role of occupational health services in workplace drug testing.
    Lillsunde P, Mukala K, Partinen R, Lamberg M.
    Forensic Sci Int; 2008 Jan 30; 174(2-3):103-6. PubMed ID: 17467212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Random drug testing: a commitment to a drug free workplace.
    Smith NG.
    AAOHN J; 1993 Apr 30; 41(4):193-4. PubMed ID: 8507286
    [No Abstract] [Full Text] [Related]

  • 9. Comprehensive drug-abuse program can prove effective in the workplace.
    Marini GA.
    Occup Health Saf; 1991 Apr 30; 60(4):54, 56, 58-9. PubMed ID: 2052276
    [No Abstract] [Full Text] [Related]

  • 10. National indications of increasing investment in workplace health promotion programs by large- and medium-size companies.
    Childress JM, Lindsay GM.
    N C Med J; 2006 Apr 30; 67(6):449-52. PubMed ID: 17393710
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Courts settle difficult questions regarding workplace drug testing.
    Porro J.
    Occup Health Saf; 1989 Nov 30; 58(12):48, 50. PubMed ID: 2594303
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A new challenge for drug-free workplace programs.
    DuPont RL, Martin DM, Skipper GE.
    Occup Health Saf; 2012 Feb 30; 81(2):32, 34. PubMed ID: 22435238
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.